Cat.#: ACPP-1278
| Despition | EAAT1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1573 | Human YWHAG Protein, His (AC1573) | 2 µg | inquiry |
| ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
| ACPP-1556 | Human SMARCA4 Protein (AC1556) | 5 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
| ACPP-1131 | Recombinant Human/Murine/Rat BDNF Protein (AC1131) | 50 µg | inquiry |
| ACPP-1524 | Human TARDBP (1-414) Protein (AC1524) | 5 µg | inquiry |
| ACPP-1476 | Human ENSA Protein (AC1476) | 5 µg | inquiry |
| ACPP-1693 | Human CDK1 Protein (AC1693) | 5 µg | inquiry |
| ACPP-1136 | TYRO3 Blocking Peptide (AC1136) | 250 µg | inquiry |
| ACPP-1255 | MC3 Receptor Blocking Peptide (AC1255) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.